Ways to successful strategies in drug research and development:
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
Weinheim [u.a.]
VCH
1996
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII, 265 S. graph. Darst. |
| ISBN: | 3527294155 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010633894 | ||
| 003 | DE-604 | ||
| 005 | 20221223 | ||
| 007 | t | ||
| 008 | 960219s1996 gw d||| |||| 00||| ger d | ||
| 016 | 7 | |a 946760349 |2 DE-101 | |
| 020 | |a 3527294155 |c Pp. : DM 128.00 |9 3-527-29415-5 | ||
| 035 | |a (OCoLC)35137254 | ||
| 035 | |a (DE-599)BVBBV010633894 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 |a DE-12 |a DE-20 |a DE-91G |a DE-522 |a DE-578 | ||
| 050 | 0 | |a RM301.25 | |
| 082 | 0 | |a 615.1072 |2 20 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 084 | |a MED 240f |2 stub | ||
| 084 | |a MED 960f |2 stub | ||
| 084 | |a CIT 410f |2 stub | ||
| 084 | |a CHE 893f |2 stub | ||
| 100 | 1 | |a Sedlacek, Hans-Harald |d 1943- |e Verfasser |0 (DE-588)1029511926 |4 aut | |
| 245 | 1 | 0 | |a Ways to successful strategies in drug research and development |c H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid |
| 264 | 1 | |a Weinheim [u.a.] |b VCH |c 1996 | |
| 300 | |a XIII, 265 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Farmacologia |2 larpcal | |
| 650 | 4 | |a Drug Evaluation | |
| 650 | 4 | |a Drug Industry |x organization & administration | |
| 650 | 4 | |a Drugs |x Research |x Methodology | |
| 650 | 4 | |a Ethics, Pharmacy | |
| 650 | 4 | |a Research |x organization & administration | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizinische Ethik |0 (DE-588)4074672-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 0 | 1 | |a Medizinische Ethik |0 (DE-588)4074672-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Sapienza, Alice M. |e Verfasser |0 (DE-588)170563537 |4 aut | |
| 700 | 1 | |a Eid, Volker |d 1940-2022 |e Verfasser |0 (DE-588)106239805 |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007094653&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007094653 | ||
Datensatz im Suchindex
| _version_ | 1804125109288435712 |
|---|---|
| adam_text | H. HARALD SEDLACEK ALICE M. SAPIENZA VOLKER EID WAYS TO SUCCESSFUL
STRATEGIES IN DRUG RESEARCH AND DEVELOPMENT WEINHEIM * NEW YORK BASEL *
CAMBRIDGE TOKYO CONTENTS I INTRODUCTION 1 A CHARACTERIZATION OF THE
PHARMACEUTICAL MARKET 1 B DRIVING FORCES FOR THE FUTURE 4 C CONTROLS ON
PRICING 7 D CONTROL ON UTILIZATION 10 E PERSPECTIVES 14 II THE ETHICAL
BACKGROUND 25 A DEFINITION OF ETHICS 25 1 MORAL RESPONSIBILITY 25 2
MORAL VALUES AND RULES 27 B CHANGES IN MORAL VALUES 29 1 SOCIAL CHANGES
IN UNDERSTANDING 29 2 SOCIAL DISCOURSE, PUBLIC OPINION AND PRESSURES 30
3 THE ROLE OF SCIENCE 33 C ETHICAL GOALS 35 1 HEALTHCARE 35 2 RESEARCH
FOR NEW DRUGS 38 SELECTION OF THE R&D PROJECT 39 HUMAN RIGHTS 40 3
SETTING OF PRIORITIES 42 4 RESPONSIBILITY OF SOCIAL PARTNERS 44 III THE
RESEARCH AND DEVELOPMENT PROJECT 49 A THE PROCESS OF RESEARCH AND
DEVELOPMENT 49 B THE INNOVATION PROCESS 51 C THE EVALUATION OF A PROJECT
57 1 PHARMACOLOGICAL PROFILE 60 2 MEDICAL NEEDS 60 3 MARKET AND TURNOVER
POTENTIAL 60 4 RISK FACTORS 67 5 ACTIVITIES AND EXPENSES UP TILL LAUNCH
AND POST-LAUNCH 6S XII CONTENTS 6 ESTIMATED SUCCESS OF MARKETING 74 7
VARIABILITY AND ACCURACY OF PROJECT EVALUATION 76 D THE COMPARISON OF
THE COMPANY S OWN PROJECTS 76 1 INNOVATION AND EXPERTISE 77 2 TURNOVER
POTENTIAL, COSTS AND OVERALL RISKS 79 3 DEVELOPMENT TIME AND MARKET
POSITION 80 E THE SELECTION OF MAIN R&D AREAS, GOALS AND STRATEGIES 81 1
SWOT ANALYSIS 81 2 SELECTION OF MAIN R&D AREA 83 3 DEFINITION OF GOALS
84 4 FORMULATION OF STRATEGIES 87 IV MEASURES TO REDUCE RISKS 91 A
CHOICE OF TECHNOLOGY 91 B REINFORCED SELECTION OF RESEARCH PROJECTS 96 C
DESIGNATION OF MULTIPLE GOALS AND PARTNERSHIPS 98 V PROJECT MANAGEMENT
103 A HISTORICAL CONTEXT 103 B ORGANIZATIONAL THEORIES 104 1
ORGANIZATION STRUCTURE 104 2 LIFE CYCLE MODELS AND GROWTH 107 3
TECHNOLOGY TRANSFER AND COMMUNICATION 109 4 CREATIVE GROUP PROBLEM
SOLVING 113 VI CORPORATE AND TECHNOLOGY STRATEGY 115 A TECHNOLOGY
STRATEGY H5 B TECHNOLOGY STRATEGY VECTORS 117 1 MAGNITUDE 119 2
DIRECTION 119 C TECHNOLOGY STRATEGY ARCHETYPES 123 VII LEADERSHIP AND
MANAGEMENT 127 A LEADERSHIP THEORIES 127 B WHAT IS LEADERSHIP AND
MANAGEMENT IN R&D? 134 C LEADERSHIP AND STRUCTURE 135 D THE MATRIX
CHALLENGES 135 1 COEXISTENCE OF VERTICAL AND LATERAL STRUCTURES 137 2
PERFORMANCE EVALUATION 137 THE PROJECT MANAGER 13 INDIVIDUAL TEAM
MEMBERS 13 THE TEAM 14 CONTENTS XIII FUNCTIONAL AND DISCIPLINE HEADS
140 THE HEAD OF PROJECT MANAGEMENT 140 E CHARACTERISTICS OF THE GOOD
LEADER 141 VIII MANAGING FOR INNOVATION 145 A MOTIVATION 145 1
MOTIVATION THEORIES 146 2 BASIC CONDITIONS FOR MOTIVATION IN R&D 150 3
MATCHING MOTIVATIONAL NEEDS TO THE JOB 151 THREE WORK-RELATED NEEDS 152
EXPRESSION OF MOTIVATIONAL NEEDS 153 4 THE MOTIVATED AND CREATIVE R&D
ORGANIZATION 154 B CULTURE 156 1 THE OUTER LEVEL: MANIFESTATIONS 156 2
BELOW THE SURFACE: JUSTIFICATION 156 3 AT THE HEART OF CULTURE: CORE
IDEOLOGY 158 4 CULTURE AND CREATIVITY 160 C ORGANIZATIONAL SYSTEM 162 1
RECRUITMENT 162 2 PERFORMANCE APPRAISAL AND REWARD SYSTEMS 163 3
DECISION-MAKING AND APPROVAL SYSTEMS 164 4 INFORMATION SYSTEMS 165 D
ORGANIZATIONAL STRUCTURES AND ACTIVITIES 1 66 IX THE SOCIAL AND
POLITICAL BEARINGS ON INNOVATION 177 A BACKGROUND 177 B CONSTRAINING
PRESSURES 179 C ECONOMIC CONSTRAINTS 185 D THE ROLE OF THE INDUSTRY 191
X ETHICAL OBLIGATIONS 195 A AUTONOMY OF PATIENTS 195 B EXPERIMENTS ON
AND PROTECTION OF ANIMALS 199 C CLINICAL TRIALS 210 D TECHNOLOGIES 224 E
HEALTH CARE AND INFORMATION ACTIVITIES 236 REFERENCES 241 INDEX 253
|
| any_adam_object | 1 |
| author | Sedlacek, Hans-Harald 1943- Sapienza, Alice M. Eid, Volker 1940-2022 |
| author_GND | (DE-588)1029511926 (DE-588)170563537 (DE-588)106239805 |
| author_facet | Sedlacek, Hans-Harald 1943- Sapienza, Alice M. Eid, Volker 1940-2022 |
| author_role | aut aut aut |
| author_sort | Sedlacek, Hans-Harald 1943- |
| author_variant | h h s hhs a m s am ams v e ve |
| building | Verbundindex |
| bvnumber | BV010633894 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.25 |
| callnumber-search | RM301.25 |
| callnumber-sort | RM 3301.25 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 5350 |
| classification_tum | MED 240f MED 960f CIT 410f CHE 893f |
| ctrlnum | (OCoLC)35137254 (DE-599)BVBBV010633894 |
| dewey-full | 615.1072 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1072 |
| dewey-search | 615.1072 |
| dewey-sort | 3615.1072 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Chemie Chemie-Ingenieurwesen Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02234nam a2200565 c 4500</leader><controlfield tag="001">BV010633894</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221223 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960219s1996 gw d||| |||| 00||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">946760349</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527294155</subfield><subfield code="c">Pp. : DM 128.00</subfield><subfield code="9">3-527-29415-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35137254</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010633894</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-91G</subfield><subfield code="a">DE-522</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1072</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 240f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 960f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CIT 410f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 893f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sedlacek, Hans-Harald</subfield><subfield code="d">1943-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1029511926</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ways to successful strategies in drug research and development</subfield><subfield code="c">H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim [u.a.]</subfield><subfield code="b">VCH</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 265 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacologia</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Methodology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethics, Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinische Ethik</subfield><subfield code="0">(DE-588)4074672-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizinische Ethik</subfield><subfield code="0">(DE-588)4074672-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sapienza, Alice M.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)170563537</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eid, Volker</subfield><subfield code="d">1940-2022</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)106239805</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007094653&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007094653</subfield></datafield></record></collection> |
| id | DE-604.BV010633894 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:56:20Z |
| institution | BVB |
| isbn | 3527294155 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007094653 |
| oclc_num | 35137254 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-20 DE-91G DE-BY-TUM DE-522 DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-20 DE-91G DE-BY-TUM DE-522 DE-578 |
| physical | XIII, 265 S. graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | VCH |
| record_format | marc |
| spelling | Sedlacek, Hans-Harald 1943- Verfasser (DE-588)1029511926 aut Ways to successful strategies in drug research and development H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid Weinheim [u.a.] VCH 1996 XIII, 265 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Farmacologia larpcal Drug Evaluation Drug Industry organization & administration Drugs Research Methodology Ethics, Pharmacy Research organization & administration Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Medizinische Ethik (DE-588)4074672-0 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 s Medizinische Ethik (DE-588)4074672-0 s DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s Sapienza, Alice M. Verfasser (DE-588)170563537 aut Eid, Volker 1940-2022 Verfasser (DE-588)106239805 aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007094653&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Sedlacek, Hans-Harald 1943- Sapienza, Alice M. Eid, Volker 1940-2022 Ways to successful strategies in drug research and development Farmacologia larpcal Drug Evaluation Drug Industry organization & administration Drugs Research Methodology Ethics, Pharmacy Research organization & administration Arzneimittelentwicklung (DE-588)4143176-5 gnd Medizinische Ethik (DE-588)4074672-0 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4074672-0 (DE-588)4003120-2 |
| title | Ways to successful strategies in drug research and development |
| title_auth | Ways to successful strategies in drug research and development |
| title_exact_search | Ways to successful strategies in drug research and development |
| title_full | Ways to successful strategies in drug research and development H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid |
| title_fullStr | Ways to successful strategies in drug research and development H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid |
| title_full_unstemmed | Ways to successful strategies in drug research and development H. Harald Sedlacek ; Alice M. Sapienza ; Volker Eid |
| title_short | Ways to successful strategies in drug research and development |
| title_sort | ways to successful strategies in drug research and development |
| topic | Farmacologia larpcal Drug Evaluation Drug Industry organization & administration Drugs Research Methodology Ethics, Pharmacy Research organization & administration Arzneimittelentwicklung (DE-588)4143176-5 gnd Medizinische Ethik (DE-588)4074672-0 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| topic_facet | Farmacologia Drug Evaluation Drug Industry organization & administration Drugs Research Methodology Ethics, Pharmacy Research organization & administration Arzneimittelentwicklung Medizinische Ethik Arzneimittelforschung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007094653&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT sedlacekhansharald waystosuccessfulstrategiesindrugresearchanddevelopment AT sapienzaalicem waystosuccessfulstrategiesindrugresearchanddevelopment AT eidvolker waystosuccessfulstrategiesindrugresearchanddevelopment |